Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …

Fungal endocarditis accounts for 1% to 3% of all infective endocarditis cases, is associated
with high morbidity and mortality (> 70%), and presents numerous challenges during clinical …

Purpose: COVID-19-associated rhino-orbital-cerebral mucormycosis (ROCM) has reached
epidemic proportion during India's second wave of COVID-19 pandemic, with several risk …

Reports are increasing on the emergence of COVID‐19–associated mucormycosis (CAM)
globally, driven particularly by low‐and middle‐income countries. The recent unprecedented …

Gastrointestinal fungal dysbiosis is a hallmark of several diseases marked by systemic
immune activation. Whether persistent pathobiont colonization during immune alterations …

Purpose The aim of the study was to report clinical features, contributing factors and
outcome of patients with coronavirus disease 2019 (COVID‐19)‐associated mucormycosis …

Individuals suffering from severe viral respiratory tract infections have recently emerged as
“at risk” groups for developing invasive fungal infections. Influenza virus is one of the most …

Abstract Coronavirus disease 2019 (COVID-19) can become complicated by secondary
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …

The epidemiology of invasive fungal infections is changing, with new populations at risk and
the emergence of resistance caused by the selective pressure from increased usage of …

Background Mucormycosis, a rare fungal infection, has shown an increase in the number of
reported cases during the COVID-19 pandemic. Objectives To provide a comprehensive …